Alfred Sandrock

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Alfred Sandrock
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alfred Sandrock:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOGEN INC. Head of Research & Development Common Stock 10,169 $2,521,940 $248.00 07 Jun 2021 Direct
Voyager Therapeutics, Inc. President and CEO, Director Common Stock 430,931 $1,478,093 $3.43 02 Apr 2025 Direct
Voyager Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 290,000 21 Feb 2025 Direct

Insider Reports Filed by Alfred Sandrock

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYGR Voyager Therapeutics, Inc. 02 Apr 2025 1 -$37,336 4 President and CEO, Director 04 Apr 2025, 16:08
VYGR Voyager Therapeutics, Inc. 20 Feb 2025 3 -$49,616 4 President and CEO, Director 24 Feb 2025, 16:20
VYGR Voyager Therapeutics, Inc. 11 Feb 2025 1 -$74,066 4 President & CEO 12 Feb 2025, 16:20
VYGR Voyager Therapeutics, Inc. 02 Apr 2024 1 -$119,454 4 President and CEO, Director 03 Apr 2024, 16:10
VYGR Voyager Therapeutics, Inc. 21 Feb 2024 1 -$97,226 4 President and CEO, Director 22 Feb 2024, 16:34
VYGR Voyager Therapeutics, Inc. 09 Feb 2024 2 $0 4 President and CEO, Director 16 Feb 2024, 16:59
VYGR Voyager Therapeutics, Inc. 03 Apr 2023 1 -$58,232 4 President and CEO, Director 05 Apr 2023, 17:04
VYGR Voyager Therapeutics, Inc. 17 Feb 2023 2 $0 4 President and CEO, Director 22 Feb 2023, 19:51
VYGR Voyager Therapeutics, Inc. 22 Mar 2022 2 $0 4 President and CEO, Director 23 Mar 2022, 18:35
VYGR Voyager Therapeutics, Inc. 07 Feb 2022 1 $0 4 Director 09 Feb 2022, 15:27
VYGR Voyager Therapeutics, Inc. 07 Feb 2022 0 $0 3 Director 09 Feb 2022, 15:25
BIIB BIOGEN INC. 07 Jun 2021 1 -$3,375,680 4 Head of Research & Development 09 Jun 2021, 19:05